Clinical Edge Journal Scan

Greater joint damage and higher disease activity increases risk for surgery in PsA


 

Key clinical point: Increasing disease activity and joint damage were significant risk factors for requiring musculoskeletal (MSK) surgery in patients with psoriatic arthritis (PsA).

Major finding: A greater number of damaged joints (hazard ratio [HR] 1.032; P < .001), presence of nail lesions (HR 2.079; P < .006), higher health assessment questionnaire scores (HR 2.012; P < .001), an elevated erythrocyte sedimentation rate (HR 2.365; P = .017), a greater number of actively inflamed joints (HR 1.037; P = .007), and human leukocyte antigen-B*27 positivity (HR 2.217; P = .048) were associated with an increased risk for surgery.

Study details: Findings are from a longitudinal, observational cohort study including 1574 patients with PsA, of which 11.8% underwent ≥1 MSK surgery attributable to PsA.

Disclosures: This study was supported by the Krembil Foundation, Toronto. The authors declared no conflicts of interest.

Source: Kwok TSH et al. Musculoskeletal surgery in psoriatic arthritis: Prevalence and risk factors. J Rheumatol. 2022 (Nov 15). Doi: 10.3899/jrheum.220908

Recommended Reading

Treg cells and serum Treg-associated cytokines play an important role in PsA pathogenesis
MDedge Rheumatology
Wide variance described in lab monitoring of conventional synthetic DMARDs
MDedge Rheumatology
Skinny-label biosimilars provide substantial savings to Medicare
MDedge Rheumatology
Commentary: Sex differences, pregnancy, a quicker CRP test, and new drugs in PsA, December 2022
MDedge Rheumatology
Vaccination cuts long COVID risk for rheumatic disease patients
MDedge Rheumatology
Bimekizumab shows promise in PsA patients naive to bDMARD
MDedge Rheumatology
BNT162b2 booster dose highly recommended for PsA patients on TNF inhibitors
MDedge Rheumatology
Bimekizumab beneficial in PsA patients with inadequate response to or intolerance of TNFα inhibitors
MDedge Rheumatology
Nailfold capillary abnormalities predict PsA in patients with psoriasis
MDedge Rheumatology
Understanding the bidirectional causal link between Crohn’s disease and PsA
MDedge Rheumatology